A Study of ONO-1110 in Patients With Postherpetic Neuralgia

PHASE2RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 12, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

August 31, 2026

Conditions
Postherpetic Neuralgia
Interventions
DRUG

ONO-1110

ONO-1110 tablets once a day

DRUG

Placebo

Placebo tablets once daily

Trial Locations (28)

Unknown

RECRUITING

Kamezawa Clinic, Aichi

RECRUITING

Kimura Clinic, Aichi

RECRUITING

Fukuoka Tokushukai Hospital, Fukuoka

RECRUITING

Southern Tohoku General Hospital, Fukushima

RECRUITING

Central Japan International Medical Center, Gifu

RECRUITING

National Hospital Organization Kure Medical Center, Hiroshima

RECRUITING

National Hospital Organization Hokkaido Medical Center, Hokkaido

RECRUITING

Nishinomiya Municipal Central Hospital, Hyōgo

RECRUITING

Mito Saiseikai General Hospital, Ibaraki

RECRUITING

Kawasaki Municipal Hospital, Kanagawa

RECRUITING

Konan Hidamari Pain Clinic, Kanagawa

RECRUITING

Tai Clinic, Kanagawa

RECRUITING

Yokohama City Minato Red Cross Hospital, Kanagawa

RECRUITING

Junwakai Memorial Hospital, Miyazaki

RECRUITING

Medical Corporation Toyama Dermatology, Miyazaki

RECRUITING

Yuaikai Tomishiro Chuo Hospital, Okinawa

RECRUITING

Morimoto Clinic, Osaka

RECRUITING

Osaka Metropolitan University Hospital, Osaka

RECRUITING

Medical Corporation Fujigaki Clinic, Ōita

RECRUITING

Shizuoka Rehabili Pain Clinic, Shizuoka

RECRUITING

Fukuuchi Pain Clinic, Tokyo

RECRUITING

Fukuwa Clinic, Tokyo

RECRUITING

Futaki Skin Care Clinic, Tokyo

RECRUITING

Juntendo University Hospital, Tokyo

RECRUITING

Mitaka Pain Clinic, Tokyo

RECRUITING

Nishiogi Pain Clinic, Tokyo

RECRUITING

Tokyo-Eki Center-Building Clinic, Tokyo

RECRUITING

Yamanashi Prefectural Central Hospital, Yamanashi

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY